Jubilant Pharmova Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 15,665 million compared to INR 14,405 million a year ago. Revenue was INR 15,955 million compared to INR 14,630 million a year ago.

Net income was INR 64 million compared to INR 471 million a year ago. Basic earnings per share from continuing operations was INR 0.4 compared to INR 2.96 a year ago. Diluted earnings per share from continuing operations was INR 0.4 compared to INR 2.96 a year ago.